| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oyster Point Pharma, Inc. | Director | Common Stock | 0 | $11.20 | 03 Jan 2023 | Direct | |
| Oyster Point Pharma, Inc. | Director | Stock Option (Right to Buy) | 0 | 03 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123001065-eliades-george-christopher-2023-01-03 | Oyster Point Pharma, Inc. | 03 Jan 2023 | 4 | $0 | 4 | Director | 04 Jan 2023, 16:03 |
| /report/000120919122035065-eliades-george-christopher-2022-06-06 | Oyster Point Pharma, Inc. | 06 Jun 2022 | 2 | $0 | 4 | Director | 08 Jun 2022, 16:48 |
| /report/000120919121039348-eliades-george-christopher-2021-06-07 | Oyster Point Pharma, Inc. | 07 Jun 2021 | 2 | $0 | 4 | Director | 09 Jun 2021, 20:54 |